journal article·2024-02-09

Multifunctional Pd Single-Atom Nanozyme for Enhanced Cascade Chemodynamic Therapy of Chronic Wounds

Xiaoyu Xu, Juyang Zhang, Xinye Wang, Huiyi Fang, Shaoze Shi, Fan Wu, Ninglin Zhou, Jian Shen, Baohong Sun

ACS Applied Nano Materials· Volume 7· Issue 3
Publisher page

Abstract

Nanozymes are considered promising therapeutic agents for infected chronic wounds due to their enzyme-like activity-mediated chemodynamic therapy (CDT). However, they still suffer from low catalytic efficiency and incapacity to address excessive glucose and heightened inflammatory responses in chronic wounds. Herein, we bound Pd sites to CeO 2 nanosheets in atomically dispersed form by high-temperature calcination, followed by loading glucose oxidase (GOx) to obtain Pd–CeO 2 @GOx single-atom nanozymes (SANZs) for enhanced cascade CDT of chronic wounds. Specifically, highly endogenous glucose first activates the catalytic activity of GOx for in situ self-supplement of H 2 O 2 and protons. Then, in an acidic microenvironment, the Pd single atoms exert efficient glutathione peroxidase (GSH-Px) mimicking to amplify peroxidase (POD)-mimicking activity, generating burst • OH to eradicate Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus pathogens and suppress biofilm formation. Finally, Pd sites promote the catalase (CAT)-mimicking activity of CeO 2 carriers to convert the remaining H 2 O 2 to O 2, which relieves inflammatory responses and contributes to blood vessel reconstruction in wounds. This cascade CDT strategy by Pd–CeO 2 @GOx SANZs could accelerate the healing of chronic wounds within 17 days. Therefore, this study opens up insights into the rational design of multienzyme active SANZs for the therapy of chronic wounds.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Carbon and Quantum Dots Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing 210023, China

Key Laboratory of Cardiovascular & Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China

Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, School of Pharmacy, Bengbu Medical University, Bengbu 233030, China

Funding

Natural Science Foundation of Jiangsu Province · Jiangsu Provincial Key Laboratory of Biofunctional Materials, Nanjing Normal University · Jiangsu Collaborative Innovation Center of Biomedical Functional Materials · Jiangsu Engineering Research Center for Biomedical Function Materials

References (51)

Show source-provided references
1. 10.1002/smll.20220548910.1002/smll.202205489 ↗
2. 10.1002/smll.20220089510.1002/smll.202200895 ↗
3. 10.1016/j.nantod.2020.10094610.1016/j.nantod.2020.100946 ↗
4. 10.1016/j.nantod.2021.10116210.1016/j.nantod.2021.101162 ↗
5. 10.1002/adma.20221104110.1002/adma.202211041 ↗
6. 10.1016/j.actbio.2022.02.03410.1016/j.actbio.2022.02.034 ↗
7. 10.1002/anie.20190564510.1002/anie.201905645 ↗
8. 10.1126/sciadv.aav549010.1126/sciadv.aav5490 ↗
9. 10.1039/D0SC03522J10.1039/D0SC03522J ↗
10. 10.1002/adma.20221172410.1002/adma.202211724 ↗
11. 10.1002/smll.20190148510.1002/smll.201901485 ↗
12. 10.1016/j.actbio.2023.03.04010.1016/j.actbio.2023.03.040 ↗
13. 10.1021/acsami.1c1968110.1021/acsami.1c19681 ↗
14. 10.1016/j.jconrel.2020.06.00310.1016/j.jconrel.2020.06.003 ↗
15. 10.1002/adhm.20210071610.1002/adhm.202100716 ↗
16. 10.1016/j.cej.2023.14338610.1016/j.cej.2023.143386 ↗
17. 10.1016/j.biomaterials.2019.11925410.1016/j.biomaterials.2019.119254 ↗
18. 10.1039/D0NR03135F10.1039/D0NR03135F ↗
19. 10.1039/D0SC06742C10.1039/D0SC06742C ↗
20. 10.1007/s12274-022-4359-610.1007/s12274-022-4359-6 ↗
21. 10.1002/adfm.20211026810.1002/adfm.202110268 ↗
22. 10.1002/adfm.20170637510.1002/adfm.201706375 ↗
23. 10.1016/j.biomaterials.2014.10.06510.1016/j.biomaterials.2014.10.065 ↗
24. 10.1002/smll.20200465410.1002/smll.202004654 ↗
25. 10.1021/acsami.1c1082110.1021/acsami.1c10821 ↗
26. 10.1016/j.biomaterials.2020.11992310.1016/j.biomaterials.2020.119923 ↗
27. 10.1016/j.bioactmat.2022.01.03610.1016/j.bioactmat.2022.01.036 ↗
28. 10.1021/jacs.2c0899210.1021/jacs.2c08992 ↗
29. 10.1021/acscatal.6b0244710.1021/acscatal.6b02447 ↗
30. 10.1021/acscatal.0c0332410.1021/acscatal.0c03324 ↗
31. 10.1021/ja909131k10.1021/ja909131k ↗
32. 10.1002/ange.20171041810.1002/ange.201710418 ↗
33. 10.1021/acsami.0c1521110.1021/acsami.0c15211 ↗
34. 10.1002/smll.20190389510.1002/smll.201903895 ↗
35. 10.1002/anie.20210192410.1002/anie.202101924 ↗
36. 10.1016/j.biomaterials.2021.12132510.1016/j.biomaterials.2021.121325 ↗
37. 10.1021/acs.nanolett.9b0093410.1021/acs.nanolett.9b00934 ↗
38. 10.1021/acsami.9b1160710.1021/acsami.9b11607 ↗
39. 10.1021/acsnano.3c0540910.1021/acsnano.3c05409 ↗
40. 10.1021/acsanm.2c0064410.1021/acsanm.2c00644 ↗
41. 10.1002/smll.20210546510.1002/smll.202105465 ↗
42. 10.1039/C9TB01683J10.1039/C9TB01683J ↗
43. 10.1016/j.bioactmat.2021.04.02410.1016/j.bioactmat.2021.04.024 ↗
44. 10.1002/smll.20210546510.1002/smll.202105465 ↗
45. 10.1016/j.nantod.2022.10138010.1016/j.nantod.2022.101380 ↗
46. 10.1021/acsami.1c0761210.1021/acsami.1c07612 ↗
47. 10.1002/adma.20210901010.1002/adma.202109010 ↗
48. 10.1002/adfm.20230515410.1002/adfm.202305154 ↗
49. 10.1002/smll.20230258710.1002/smll.202302587 ↗
50. 10.1002/adma.20220806910.1002/adma.202208069 ↗
51. 10.2353/ajpath.2009.08108010.2353/ajpath.2009.081080 ↗